
Communication and Compliance Go Hand in Hand
EULAR 2016: Patient education and compliance often take a back seat to disease management, but they need to be at the forefront of care.
Although patient education and patient adherence often take a back seat to medication management in rheumatoid arthritis (RA), several studies reported at the European League Against Rheumatism Annual Congress (EULAR 2016) in London last week, highlight the importance of better education and participation. The studies found that more active patient involvement led to better outcomes. Here is a summary of three of those studies:
Text Messaging Boosts Health Status in Rheumatoid Arthritis
A group of rheumatoid arthritis patients who received
There was a significant between-group difference in mean daily sitting time-the group of rheumatoid arthritis patients had a mean decrease of 1.61 hours per day versus 0.59 hours per day in the control group. The intervention group also saw beneficial differences in pain, fatigue and physical function.
A study reported last year in
Patients Left with Unanswered Questions, Spurs Nonadherence
Many patients may be satisfied with their
“Further understanding the responses from the survey will be important to facilitate communication between patients and healthcare providers, with the aim of improving treatment outcomes,” wrote lead abstract author Cheryl Koehn, Arthritis Consumer Experts, Vancouver.
Developed by the RA NarRAtive Global Advisory Panel, which includes 39 global RA experts (some of whom have RA), the survey included 3,649 patients. The average age was 52.8 years, and the median time since rheumatoid arthritis diagnosis was seven years. Thirty-four percent of respondents classified their current health as excellent/good. Although 78 percent of patients were satisfied with their rheumatoid arthritis medications, 70 percent wanted to take fewer medications; 57 percent worried their medications would fail, and 59 percent wanted more medication choices.
“The number or dosing frequency of medications was the most frequently cited aspect that patients would most like to change with respect to their current prescribed medications,” the abstract authors wrote. Still, 62 percent of patients were uncomfortable raising treatment concerns with their healthcare provider as they did not want to appear difficult.
“Expert” Patients, an Invaluable Resource for Developing Education Programs
The update of a
In the program, Patient Partners are expert patients who help train medical students, general practitioners and other providers about rheumatoid arthritis. Participants decided to update the Patient Partners Program for rheumatoid arthritis based on changing needs about early intensive treatment and patient beliefs and preferences in early rheumatoid arthritis. Based on the patient involvement and perspectives, program leaders created four content modules: aspects of treatment participation, perceptions about medication, the patient and his/her environment, and active participation.
“Making medical students and healthcare providers aware of the patient perspective is an important step towards optimal care in RA,” the abstract authors concluded.
Disclosures:
The surveys for Koehn’s study were funded by Pfizer Inc.
References:
1. Thomsen T, Aadahl M, Beyer N, et al. “
2. Baron-Faust R. “
3. Koehn C, Dikranian A, Maniccia A, Bananis E. “
4. Van Rompay J, Hoet A, Geysen C, et al. “




